Clinical trial · Interventional
Limberg and Karydakis Flap in Recurrent Pilonidal Sinus Disease
Effectiveness of Limberg and Karydakis Flap in Recurrent Pilonidal Sinus Disease
NCT02287935CI-TRIAL-00016041completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
It was investigated whether there is a factor that can aid determination of the preferred technique by comparing the early Limberg flap and Karydakis procedure techniques for the treatment of recurrent pilonidal sinus.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Recurrent Pilonidal Sinus Disease | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Karydakis procedure | Procedure | — | UNRESOLVED |
| Limberg flap | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Limberg flap
- description
- Patients were divided into two groups, group 1 were treated with Limberg flap technique
- interventionNames
- Procedure: Limberg flap
- type
- ACTIVE_COMPARATOR
- label
- Karydakis procedure
- description
- Patients were divided into two groups, group 2 were treated with Karydakis procedure
- interventionNames
- Procedure: Karydakis procedure
Primary outcomes (1)
- measure
- Superiority of Limberg Flap in Recurrent Pilonidal Sinus Disease
- timeFrame
- January 2009 to December 2013, Patients were invited for control 1 month, 3 months, 6 months, 1 year intervals
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 16 Years
- Maximum age
- 40 Years
Show eligibility criteria text
Inclusion Criteria: 1. Patients willing to give written informed consent 2. There should be recurrent pilonidal sinus 2\. Recurrent adult patients (over 18 years of age) undergoing surgery for pilonidal sinus 3\. International normalizing ratio (INR) less than 1.5 4\. Prothrombin time (PT) should be less than 15 s 5\. Partial thromboplastin (PTT) time should be near normal 6\. Platelet count should be greater than 50,000 per mm3 to limit the risk of bleeding 7\. There must be no infection at the time of surgery \- Exclusion Criteria: 1. Patients not willing to give informed consent 2. Age less than 16 years 3. Patient presenting with conditions mimicking pilonidal sinus 4. Diabetes mellitus, renal failure, immunosuppression e.g. were excluded \-
References
Publications (1)
- DERIVEDBali I, Aziret M, Sozen S, Emir S, Erdem H, Cetinkunar S, Irkorucu O. Effectiveness of Limberg and Karydakis flap in recurrent pilonidal sinus disease. Clinics (Sao Paulo). 2015 May;70(5):350-5. doi: 10.6061/clinics/2015(05)08. Epub 2015 May 1. PMID 26039952